2021
Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States
Boczar D, Bagaria SP, Spaulding AC, Huayllani MT, Avila FR, Guliyeva G, Lu X, Rinker BD, Forte AJ. Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States. Anticancer Research 2021, 41: 2067-2070. PMID: 33813415, DOI: 10.21873/anticanres.14976.Peer-Reviewed Original ResearchConceptsNational Cancer DatabaseMultivariate logistic regressionComorbid conditionsTreatment contraindicationsGovernment insuranceLogistic regressionUnknown treatment statusMost patientsPatient demographicsComorbidity statusCurative treatmentMelanoma patientsCancer DatabaseIndependent associationOncological patientsMelanoma incidenceTreatment decisionsInclusion criteriaHigher oddsMelanoma treatmentTreatment statusPatientsPoor candidatesPatient treatmentPrivate insurance
2020
National Analysis of Patients With Ulcerated Melanoma in the United States
Boczar D, Sisti A, Restrepo DJ, Huayllani MT, Manrique OJ, Lu X, Spaulding AC, Bagaria SP, Parker AS, Forte AJ. National Analysis of Patients With Ulcerated Melanoma in the United States. Anticancer Research 2020, 40: 1055-1058. PMID: 32014953, DOI: 10.21873/anticanres.14042.Peer-Reviewed Original ResearchConceptsUlcerated melanomaNational Cancer DatabaseNon-white patientsNon-white raceZip codesYears of agePatient disparitiesPatient demographicsMelanoma patientsTumor characteristicsMale sexUnfavorable prognosisCancer DatabaseHigher oddsLower oddsPatientsMelanomaUlcerationFacility characteristicsLower educationOddsLow incomeEducation levelUrban countiesPresent study